Market Overview:
The global cough expectorant market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing awareness about the benefits of cough expectorants, and rising demand for over-the-counter (OTC) drugs. Based on type, the global cough expectorant market can be segmented into prescription and non-prescription drugs. The prescription drug segment is expected to account for a larger share of the market in 2018 owing to their higher efficacy as compared to non-prescription drugs. However, the non-prescription drug segment is projected to grow at a faster rate during the forecast period due its easy availability and lower cost as compared to prescription drugs. Based on application, adults and children are two major segments of the global cough expectorant market. The adult segment accounted for a larger share of this market in 2017 owingto their greater susceptibilityto respiratory diseases as compared children .
Product Definition:
A cough expectorant is a medication that helps loosen up and expel mucus from the lungs, making it easier to breathe. Cough expectorants are available as liquids, tablets, or capsules. They are often combined with other medications to treat coughs, such as antitussives (cough suppressants) and decongestants.
Prescription:
Prescription is a doctor’s authorization for a particular drug or medicine. In many countries, doctors may prescribe cough syrups and other homeopathic medicines to treat common coughs as these products are easy to use and have no serious side effects. However, in some countries such as the U.S., prescription of OTC drugs is permitted due to their non-toxic nature even if they are not approved by the FDA (Food and Drug Administration).
Non-prescription:
Non-prescription or OTC products are those that are not approved by the U.S. FDA as a prescription drug; however, they can be purchased and used without a prescription. The majority of these products fall under the category of cough and cold drugs, which help reduce cough frequency and intensity as well as shorten an upcoming hacking or dry cough by triggering the release of natural antibodies in the body to fight off infection.
Application Insights:
The global market is segmented by application into adults and children. The adult segment held the largest share of over 70.0% in 2017 owing to the high prevalence of chronic coughs across various regions, such as North America and Europe. According to a study published in NCBI, around 54% of adults suffer from chronic coughs whereas only 10-15% of them have a formal diagnosis for it. Moreover, according to WHO, around 1 billion people suffer from chronic cough worldwide which leads to reduced productivity at work or school every year due to coughing for 2-3 hours daily during sleep time.
Cough is one of the most common diseases found among children which causes disruption in their routine.
Regional Analysis:
North America dominated the global cough expectorant market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness regarding various treatment options, availability of branded products, and high healthcare expenditure levels in this region. Moreover, a large number of product launches are also anticipated to contribute towards regional growth over the next eight years.
Asia Pacific is expected to witness rapid growth over the forecast period owing to rising disposable income levels and improving economic conditions in emerging countries such as India and China. Furthermore, an increase in consumer spending on health & wellness products will also support regional demand for cough expectorants during the same period.
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for cough expectorants in the coming years.
- Growing awareness about the benefits of cough expectorants: There is a growing awareness among consumers about the benefits of using cough expectorants, which is expected to boost demand for these products in the coming years.
- Rising popularity of over-the-counter (OTC) drugs: The popularity of OTC drugs is rising due to their easy availability and affordability. This is likely to boost demand for cough expectorants in the near future.
- Technological advancements in manufacturing process: The technological advancements taking place in manufacturing processes are helping manufacturers produce better quality products at lower costs, thereby driving growth prospects for this market segment globally . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Cough Expectorant Market Research Report
By Type
Prescription, Non-prescription
By Application
Adults, Children
By Companies
Novartis, Pfizer, Johnson & Johnson, Merck & Co., Roche, Sanofi, Atley Pharmaceuticals, Vertical Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Cough Expectorant Market Report Segments:
The global Cough Expectorant market is segmented on the basis of:
Types
Prescription, Non-prescription
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Pfizer
- Johnson & Johnson
- Merck & Co.
- Roche
- Sanofi
- Atley Pharmaceuticals
- Vertical Pharmaceuticals
Highlights of The Cough Expectorant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription
- Non-prescription
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cough Expectorant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cough expectorant is a medication used to relieve coughing. It works by loosening mucus and removing debris from the lungs.
Some of the major players in the cough expectorant market are Novartis, Pfizer, Johnson & Johnson, Merck & Co., Roche, Sanofi, Atley Pharmaceuticals, Vertical Pharmaceuticals.
The cough expectorant market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cough Expectorant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cough Expectorant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cough Expectorant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cough Expectorant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cough Expectorant Market Size & Forecast, 2018-2028
4.5.1 Cough Expectorant Market Size and Y-o-Y Growth
4.5.2 Cough Expectorant Market Absolute $ Opportunity
Chapter 5 Global Cough Expectorant Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cough Expectorant Market Size Forecast by Type
5.2.1 Prescription
5.2.2 Non-prescription
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cough Expectorant Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cough Expectorant Market Size Forecast by Applications
6.2.1 Adults
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cough Expectorant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cough Expectorant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cough Expectorant Analysis and Forecast
9.1 Introduction
9.2 North America Cough Expectorant Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cough Expectorant Market Size Forecast by Type
9.6.1 Prescription
9.6.2 Non-prescription
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cough Expectorant Market Size Forecast by Applications
9.10.1 Adults
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cough Expectorant Analysis and Forecast
10.1 Introduction
10.2 Europe Cough Expectorant Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cough Expectorant Market Size Forecast by Type
10.6.1 Prescription
10.6.2 Non-prescription
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cough Expectorant Market Size Forecast by Applications
10.10.1 Adults
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cough Expectorant Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cough Expectorant Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cough Expectorant Market Size Forecast by Type
11.6.1 Prescription
11.6.2 Non-prescription
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cough Expectorant Market Size Forecast by Applications
11.10.1 Adults
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cough Expectorant Analysis and Forecast
12.1 Introduction
12.2 Latin America Cough Expectorant Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cough Expectorant Market Size Forecast by Type
12.6.1 Prescription
12.6.2 Non-prescription
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cough Expectorant Market Size Forecast by Applications
12.10.1 Adults
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cough Expectorant Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cough Expectorant Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cough Expectorant Market Size Forecast by Type
13.6.1 Prescription
13.6.2 Non-prescription
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cough Expectorant Market Size Forecast by Applications
13.10.1 Adults
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cough Expectorant Market: Competitive Dashboard
14.2 Global Cough Expectorant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Pfizer
14.3.3 Johnson & Johnson
14.3.4 Merck & Co.
14.3.5 Roche
14.3.6 Sanofi
14.3.7 Atley Pharmaceuticals
14.3.8 Vertical Pharmaceuticals
